Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

ADM Invests In Biotech Rennovia

by Alexander H. Tullo
February 17, 2014 | A version of this story appeared in Volume 92, Issue 7

Agricultural processing giant Archer Daniels Midland is making a $25 million equity investment in Rennovia. The biobased chemical start-up is developing a catalytic process to make the nylon 6,6 raw materials adipic acid and hexamethylenediamine from sugar. ADM says it is impressed with Rennovia’s technology and expects the biotech’s products to join its stable of renewable chemicals such as propylene glycol and ethylene glycol. Two years ago, ADM pulled out of a joint venture with Metabolix to make the biobased plastic polyhydroxyalkanoate.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.